Jazz Pharmaceuticals to acquire Actio Biosciences for $820m upfront

Jazz Pharmaceuticals will hold a minority equity interest in the new entity. Credit: Piotr Swat / Shutterstock.com.



  • Jazz Pharmaceuticals Actio Biosciences